Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome

Publisher： Karger

E-ISSN： 2296-9160|2|3-4|120-129

ISSN： 2296-9195

Source： Skin Appendage Disorders, Vol.2, Iss.3-4, 2016-09, pp. : 120-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of 5-Alpha-Reductase and 17-Beta-Hydroxysteroid Dehydrogenase in the Infrainfundibulum of Subjects with and without Acne vulgaris

By  

Dermatology, Vol. 196, Iss. 1, 1998-03 ,pp. : 38-42

Karger

Access to resources Recommend Favorite

Melkersson-Rosenthal Syndrome and Acquired C1 Inhibitor Deficiency

By  

Dermatology, Vol. 217, Iss. 2, 2008-05 ,pp. : 114-120

Karger

Access to resources Recommend Favorite

Zileuton, an Oral 5-Lipoxygenase Inhibitor, Directly Reduces Sebum Production

By  

Dermatology, Vol. 210, Iss. 1, 2005-01 ,pp. : 36-38

Karger

Access to resources Recommend Favorite

Heterogeneity and Quantitative Differences of Type 1 5α-Reductase Expression in Cultured Skin Epithelial Cells

By  

Dermatology, Vol. 196, Iss. 1, 1998-03 ,pp. : 51-52

Karger

Access to resources Recommend Favorite

Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 213-216

Karger

Access to resources Recommend Favorite